Search - tctmd.com

Displaying 181 - 195 of 195

Sort: Relevancy | Date

Presentation THT 2024

Myocardial Recovery at the Level of the Single Myocyte

Presenter: Veli K. Topkara

March 04, 2024

Presentation THT 2024

LV Restoration: The Biology of Biological Reverse Myocardial Remodeling and Recovery

Presenter: Douglas L. Mann

March 04, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

Presentation Miami Valves 2024

Acute Myocardial Infarction Complicated with Cardiogenic Shock

Presenter: Miguel Martillo Correa

February 03, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Daily News

FDA Approves a Second Pulsed-Field Ablation System

Todd Neale

January 31, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Todd Neale

January 16, 2024

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Todd Neale

January 11, 2024

News Daily News

Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show

Michael O'Riordan

January 10, 2024

News Daily News

Exercise Testing in ANOCA Uncovers Microvascular Dysfunction

Caitlin E. Cox

January 08, 2024

News Opinion Off Script

One Hundred Years of the AHA: Looking Back to Focus on the Future

Clyde W. Yancy, MD, MSc

January 08, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

BIO

Advertisement

Myocardial Recovery at the Level of the Single Myocyte

LV Restoration: The Biology of Biological Reverse Myocardial Remodeling and Recovery

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Acute Myocardial Infarction Complicated with Cardiogenic Shock

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

FDA Approves a Second Pulsed-Field Ablation System

Less Is More: Lp(a) Much More Atherogenic Than LDL

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show

Exercise Testing in ANOCA Uncovers Microvascular Dysfunction

One Hundred Years of the AHA: Looking Back to Focus on the Future

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

Jonathan S. Reiner, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content